Condition
Atypical Parkinson Disease
Total Trials
5
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 2 (1)
Trial Status
Recruiting2
Unknown1
Completed1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06906276Recruiting
Brain Activity During Complex Walking in People With Atypical Parkinsonian Syndromes
NCT02994719Recruiting
Gait Analysis in Neurological Disease
NCT06782724Phase 2Not Yet Recruiting
Psilocybin Therapy for Psychological Distress in Palliative Patients
NCT03552484Not ApplicableCompleted
In-Home Care for Patients With PSP and Related Disorders
NCT02018406Phase 1Unknown
Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury
Showing all 5 trials